Eyenovia, Formosa Win FDA Approval for Anti-Inflammatory Eye Drops

Eyenovia, Formosa Win FDA Approval for Anti-Inflammatory Eye Drops

Source: 
BioSpace
snippet: 

Eyenovia and Taiwan-based development partner Formosa Pharmaceuticals on Monday announced that the FDA has approved their clobetasol propionate 0.05% eye drops for the treatment of post-operative inflammation and pain after eye surgery.